Cefaly Revenue and Competitors

Seraing,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Cefaly's estimated annual revenue is currently $9.5M per year.(i)
  • Cefaly's estimated revenue per employee is $251,000

Employee Data

  • Cefaly has 38 Employees.(i)
  • Cefaly grew their employee count by 3% last year.

Cefaly's People

NameTitleEmail/Phone
1
VP FinanceReveal Email/Phone
2
Marketing DirectorReveal Email/Phone
3
Senior Director OperationsReveal Email/Phone
4
Marketing DirectorReveal Email/Phone
5
Director, Business Analytics & Data ArchitectReveal Email/Phone
6
Digital Marketing ManagerReveal Email/Phone
7
Supply Chain & Production ManagerReveal Email/Phone
8
Social Media Specialist and Community ManagerReveal Email/Phone
9
Supply Chain ManagementReveal Email/Phone
10
Regional TrainerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is Cefaly?

We are a global team on a mission to solve the persistent problem of migraine through advanced therapeutic innovations. Our name, CEFALY (pronounced sef‑a‑LEE), is derived from céphalée, the French word for headache, and cephalic, a medical term that means “related to the head.“ Since 2008, we've continued to test and improve our proprietary device, CEFALY DUAL, to offer people with migraine a safe and effective, drug-free treatment. While the causes of migraine are not completely understood, current research shows that the largest and most complex cranial nerve, the trigeminal nerve, is heavily involved in the sensation of migraine headache pain. CEFALY DUAL has been specifically engineered to modify pain sensation in the trigeminal nerve through its ophthalmic branch, which runs under the skin of the forehead.

keywords:N/A

N/A

Total Funding

38

Number of Employees

$9.5M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cefaly News

2022-03-30 - External Trigeminal Nerve Stimulation device effective for At-Home Acute Migraine Treatment: Phase 3...

DARIEN, CEFALY Technology, a Belgium-based manufacturer of wearable medical devices for migraine, today announced the results of a clinical...

2022-03-30 - Secondary Data Show Continued Efficacy With Cefaly ...

At 2 hours post-stimulation, 42.5% of those on the Cefaly device had ... nerve stimulation (e-TNS) using the FDA-approved Cefaly device was...

2022-03-30 - CEFALY Publishes the First and Largest, Phase 3 Clinical ...

About the CEFALY device: CEFALY Technology is the maker of the CEFALY DUAL Enhanced, the FDA-cleared, over-the-counter wearable medical device...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A19654%N/A